Literature DB >> 1510413

Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli.

B Oliva1, G Gordon, P McNicholas, G Ellestad, I Chopra.   

Abstract

The modes of action of atypical tetracyclines that do not directly inhibit bacterial protein synthesis were investigated. The analogs tested, chelocardin, anhydrotetracycline, 6-thiatetracycline, anhydrochlortetracycline, and 4-epi-anhydrochlortetracycline, were bactericidal and caused the lysis of Escherichia coli accompanied by the release of the cytoplasmic enzyme beta-galactosidase into the supernatant. Examination by electron microscopy demonstrated that cells exposed to these analogs underwent marked morphological alterations that included the formation of numerous ghosts and the appearance of cellular debris in the culture medium. Although atypical tetracyclines promoted lysis in intact organisms, they did not cause lysis of E. coli spheroplasts, indicating that the analogs do not directly destroy the cytoplasmic membrane. These agents may promote cell lysis and death by interfering with the membrane's electrochemical gradient, which in turn leads to stimulation of autolytic enzyme activity and cellular lysis. The results support recently published data which indicate that tetracyclines are divisible into two classes on the basis of their modes of action.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510413      PMCID: PMC188751          DOI: 10.1128/AAC.36.5.913

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome.

Authors:  B Rasmussen; H F Noller; G Daubresse; B Oliva; Z Misulovin; D M Rothstein; G A Ellestad; Y Gluzman; F P Tally; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

2.  Lysis and aberrant morphology of Bacillus subtilis cells caused by surfactants and their relation to autolysin activity.

Authors:  T Tsuchido; A Svarachorn; H Soga; M Takano
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Antibacterial activity of a new thiatetracycline.

Authors:  M Bakhtiar; S Selwyn
Journal:  J Antimicrob Chemother       Date:  1983-03       Impact factor: 5.790

4.  Triggering of autolytic cell wall degradation in Escherichia coli by beta-lactam antibiotics.

Authors:  K Kitano; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli.

Authors:  R A Dixon; I Chopra
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

6.  Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli.

Authors:  C A Cherrington; M Hinton; I Chopra
Journal:  J Appl Bacteriol       Date:  1990-01

7.  Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide.

Authors:  R A Dixon; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

8.  The energized membrane and cellular autolysis in Bacillus subtilis.

Authors:  L K Jolliffe; R J Doyle; U N Streips
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

9.  Cetocycline, tetracycline analog: in vitro studies of antimicrobial activity, serum binding, lipid solubility, and uptake by bacteria.

Authors:  R Proctor; W Craig; C Kunin
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

10.  A synthetic peptide corresponding to the C-terminal 25 residues of phage MS2 coded lysis protein dissipates the protonmotive force in Escherichia coli membrane vesicles by generating hydrophilic pores.

Authors:  W H Goessens; A J Driessen; J Wilschut; J van Duin
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  25 in total

Review 1.  Ribosomal protection proteins and their mechanism of tetracycline resistance.

Authors:  Sean R Connell; Dobryan M Tracz; Knud H Nierhaus; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

2.  The antimicrobial activity of chemerin-derived peptide p4 requires oxidative conditions.

Authors:  Urszula Godlewska; Bernadetta Bilska; Aneta Zegar; Piotr Brzoza; Arkadiusz Borek; Krzysztof Murzyn; Oliwia Bochenska; Agnieszka Morytko; Patryk Kuleta; Andrzej Kozik; Elzbieta Pyza; Artur Osyczka; Brian A Zabel; Joanna Cichy
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

3.  Further characterization of Bacillus subtilis antibiotic biosensors and their use for antibacterial mode-of-action studies.

Authors:  Katherine R Mariner; Nicola Ooi; Deborah Roebuck; Alex J O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  Antibiotic resistance: Blocking tetracycline destruction.

Authors:  Sonja Petkovic; Winfried Hinrichs
Journal:  Nat Chem Biol       Date:  2017-05-08       Impact factor: 15.040

5.  Control of gene expression in Helicobacter pylori using the Tet repressor.

Authors:  Mark S McClain; Stacy S Duncan; Jennifer A Gaddy; Timothy L Cover
Journal:  J Microbiol Methods       Date:  2013-10-08       Impact factor: 2.363

6.  Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells.

Authors:  M Gossen; H Bujard
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

7.  Development of a sensitive chemiluminometric assay for the detection of beta-galactosidase in permeabilized coliform bacteria and comparison with fluorometry and colorimetry.

Authors:  S O Van Poucke; H J Nelis
Journal:  Appl Environ Microbiol       Date:  1995-12       Impact factor: 4.792

Review 8.  Tetracycline analogs whose primary target is not the bacterial ribosome.

Authors:  I Chopra
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Low Doses of Tetracycline Trigger the E. coli Growth: A Case of Hormetic Response.

Authors:  Luciana Migliore; Alice Rotini; Maria Cristina Thaller
Journal:  Dose Response       Date:  2013-05-28       Impact factor: 2.658

10.  A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter.

Authors:  Y Someya; A Yamaguchi; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.